The Administration for Strategic Preparedness and Response, an HHS agency, is working with manufacturers and government partners to identify healthcare supply-chain vulnerabilities so essential products remain available when needed.
ASPRs Center for Industrial Base Management and Supply Chain is examining dependencies across the medical production chain to find where additional domestic capability can reduce a single point of failure or dependence on a vulnerable foreign source, according to a Nov. 18 news release from the agency.
The center is mapping manufacturing plants throughout the U.S. to identify how disruptions could affect their supply of medical products. When a hurricane is forecast, the mapping can support earlier coordination with manufacturers and federal partners.
ASPR has built resilience measures into federal manufacturing contracts and agreements supported through the center and the Biomedical Advanced Research and Development Authority.
In addition, ASPR established the Biopharmaceutical Manufacturing Preparedness Consortium, which brings together partners across the biopharmaceutical supply chain to expand and reserve manufacturing capacity, strengthen access to critical supplies and advance manufacturing technologies, the release said.